{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:03:52Z","timestamp":1790946232991,"version":"4.1.0"},"reference-count":78,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Appl Thromb Hemost"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cerebral venous thrombosis (CVT), a rare cause of stroke, primarily occurs in young individuals. The established treatment regimen involves anticoagulation with low molecular weight heparin (LMWH) and vitamin K antagonists (VKA). Although direct oral anticoagulants (DOACs) have emerged as a promising alternative, their efficacy and safety remain unclear. This meta-analysis compared the efficacy and safety of DOACs versus VKA in managing CVT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Electronic databases, including PubMed, Cochrane Library, and ScienceDirect, were searched from inception until April 2025. Risk ratios (RR) with a 95% Confidence interval (CI) were pooled under the random effects model in the Review Manager 5.4.1. Quality assessment was done through the Cochrane risk of bias (RoB 2.0) tool and the Newcastle Ottawa Scale (NOS). Subgroup analyses based on study design and different types of DOACs were carried out.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirty-one studies, including five randomized controlled trials (RCTs) and 26 observational studies, were included in this meta-analysis. Our analysis showed a significant reduction in the risk of recurrent venous thromboembolism (VTE) in the DOACs arm compared to VKA (RR\u2009=\u20090.84; 95%CI: [0.71,0.99]; p\u2009=\u20090.04; I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090%). Similarly, the DOACs showed significant superiority over VKA regarding the intracranial hemorrhage (ICH) (RR\u2009=\u20090.67; 95%CI: [0.50,0.89]; p\u2009=\u20090.007; I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090%). Other endpoints, including major hemorrhage (RR\u2009=\u20090.70; 95%CI:[0.42,1.15]; p\u2009=\u20090.16; I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090%), all-cause mortality (RR\u2009=\u20090.96; 95%CI:[0.68,1.35]; p\u2009=\u20090.81; I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090%), and full recanalization (RR\u2009=\u20090.92; 95%CI:[0.82,1.03]; p\u2009=\u20090.16; I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200921%), are comparable between the two arms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>DOACs showed a significant reduction in the risk of recurrent VTE and ICH compared to VKA, whereas other endpoints are comparable. Further RCTs with a robust sample size are required to validate and confirm these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10760296251405417","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T14:47:24Z","timestamp":1765205244000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis of 4,929 Patients"],"prefix":"10.1177","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4521-3256","authenticated-orcid":false,"given":"Muhammad Hassan","family":"Waseem","sequence":"first","affiliation":[{"name":"Department of Neurology, Allama Iqbal Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain ul","family":"Abideen","sequence":"additional","affiliation":[{"name":"Department of Neurology, King Edward Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areeba","family":"Shoaib","sequence":"additional","affiliation":[{"name":"Department of Neurology, Dow University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nohela","family":"Rehman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Dow University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Osama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hayatabad Medical Complex"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barka","family":"Sajid","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jinnah Sindh Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Mukhlis","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ayub Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sania","family":"Aimen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Quetta Institute of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Wajih","family":"Ansari","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Texas Medical branch"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowaid","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Texas Medical branch"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zara","family":"Fahim","sequence":"additional","affiliation":[{"name":"Department of Neurology, King Edward Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameer Haider","family":"Cheema","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, UT Southwestern Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Bilal","family":"Zahid","sequence":"additional","affiliation":[{"name":"Department of Neurology, Allama Iqbal Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2085-8739","authenticated-orcid":false,"given":"Pawan Kumar","family":"Thada","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sotang Primary Hospital, Solukhumbu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70029-7"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105145"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.122.039579"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000456"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2023.09.096"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13381"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000024"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007903"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2018-135702"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000841"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13049-025-01337-y"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.121.007956"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2024.101508"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10448-2"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13010189"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-023-00582-9"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/10760296241256360"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"e_1_3_2_20_2","article-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins JPT","unstructured":"Higgins JPT, J T, Chandler J, et al. Cochrane handbook for systematic reviews of interventions. Cochrane Handbook for Systematic Reviews of Interventions. 20 September 2019.","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions"},{"key":"e_1_3_2_21_2","article-title":"Rob 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JAC","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. Rob 2: A revised tool for assessing risk of bias in randomised trials. Br Med J. 2019;366:l4898.","journal-title":"Br Med J."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z"},{"key":"e_1_3_2_23_2","unstructured":"Cochrane Methods GRADEing. Available from: https:\/\/methods.cochrane.org\/gradeing\/gradepro-gdt."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.2764"},{"issue":"3","key":"e_1_3_2_26_2","first-page":"125","article-title":"Evaluation of rivaroxaban versus warfarin for the treatment of cerebral vein thrombosis: A case-control blinded study","volume":"20","author":"Khorvash F","year":"2021","unstructured":"Khorvash F, Farajpour-Khanaposhtani MJ, Hemasian H, Saadatnia SM. Evaluation of rivaroxaban versus warfarin for the treatment of cerebral vein thrombosis: A case-control blinded study. Curr J Neurol. 2021;20(3):125\u2013130.","journal-title":"Curr J Neurol"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.123.044113"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/17474930241234749"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-021-02595-0"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.037541"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2022.100412"},{"issue":"1","key":"e_1_3_2_32_2","first-page":"4979210","article-title":"Clinical efficacy of conventional heparin anticoagulation combined with apixaban in the treatment of patients with cerebral venous thrombosis and its effect on Serum D-dimer and FIB expression","volume":"2021","author":"Dong X","year":"2021","unstructured":"Dong X, Liu X, Liu Y, Jiang L, Zhang H, Liu B. Clinical efficacy of conventional heparin anticoagulation combined with apixaban in the treatment of patients with cerebral venous thrombosis and its effect on Serum D-dimer and FIB expression. Comput Math Methods Med. 2021;2021(1):4979210.","journal-title":"Comput Math Methods Med"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1177\/10760296221144038"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2025.108290"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-021-01651-z"},{"issue":"6","key":"e_1_3_2_36_2","article-title":"An observational study comparing the safety and efficacy of conventional anticoagulation versus new oral anticoagulants in the management of cerebral venous Sinus thrombosis","volume":"23","author":"Shahid R","year":"2021","unstructured":"Shahid R, Zafar A, Nazish S, et al. An observational study comparing the safety and efficacy of conventional anticoagulation versus new oral anticoagulants in the management of cerebral venous Sinus thrombosis. Prim Care Companion CNS Disord. 2021;23(6).","journal-title":"Prim Care Companion CNS Disord"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-024-02586-x"},{"issue":"4","key":"e_1_3_2_38_2","first-page":"393","article-title":"Safety and efficacy of newer oral anticoagulants versus vitamin K antagonists in the management of cerebral venous thrombosis: A single-center ambispective study from south India","volume":"27","author":"Ramesh R","year":"2024","unstructured":"Ramesh R, Ranganathan LN, Raguraman S, et al. Safety and efficacy of newer oral anticoagulants versus vitamin K antagonists in the management of cerebral venous thrombosis: A single-center ambispective study from south India. Ann Indian Acad Neurol. 2024;27(4):393\u2013397.","journal-title":"Ann Indian Acad Neurol"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1404099"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106204"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1080\/21556660.2020.1838769"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1177\/1060028020952749"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02091-1"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-021-01244-x"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.006167"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.92.15_supplement.P5.3-012"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12901"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2019.00150"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1159\/000502454"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1251581"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1159\/000502454"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.94.15_supplement.1974"},{"issue":"1","key":"e_1_3_2_53_2","article-title":"Direct oral anticoagulants and vitamin K antagonists for treatment of cerebral vein thrombosis","volume":"4","author":"Capecchi M","year":"2020","unstructured":"Capecchi M, Abbattista M, Gianniello F, Artoni A, Bucciarelli P, Peyvandi F. Direct oral anticoagulants and vitamin K antagonists for treatment of cerebral vein thrombosis. Res Pract Thromb Haemost. 2020;4(S1):PB2414.","journal-title":"Res Pract Thromb Haemost"},{"key":"e_1_3_2_54_2","first-page":"8487","article-title":"Comparison of Warfarin and rivaroxaban In treatment of cerebral venous sinus thrombosis","volume":"6","author":"Faheem Saeed ZA","year":"2019","unstructured":"Faheem Saeed ZA, Ahmad N. Comparison of Warfarin and rivaroxaban In treatment of cerebral venous sinus thrombosis. Indo American Journal of Pharmaceutical Sciences. 2019;6:8487\u20138492.","journal-title":"Indo American Journal of Pharmaceutical Sciences"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2022.11.001"},{"issue":"3","key":"e_1_3_2_56_2","article-title":"Clinical Observation of Rivaroxaban and Warfarin in the Treatment of Cerebral Venous Sinus Thrombosis","volume":"12","author":"Xue L-h","year":"2022","unstructured":"Xue L-h. Clinical Observation of Rivaroxaban and Warfarin in the Treatment of Cerebral Venous Sinus Thrombosis. Acta Neuropharmacologica. 2022;12(3).","journal-title":"Acta Neuropharmacologica"},{"issue":"3","key":"e_1_3_2_57_2","first-page":"5","article-title":"Clinical observation of rivaroxaban and warfarin in the treatment of cerebral venous sinus thrombosis","volume":"12","author":"Fei-hu L","year":"2022","unstructured":"Fei-hu L, Xue Y. Clinical observation of rivaroxaban and warfarin in the treatment of cerebral venous sinus thrombosis. Acta Neuropharmacologica. 2022;12(3):5.","journal-title":"Acta Neuropharmacologica"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1869"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00519-2"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009638"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905561"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13506"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-015-1310-7"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017559"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000173152.84438.1c"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.07.040"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056355"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197583"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62343-0"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030628"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2015.9"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2019.05.024"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310907"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2019-002415"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0b013e31820a8364"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.3171\/2009.7.FOCUS09146"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.007465"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001830"}],"container-title":["Clinical and Applied Thrombosis\/Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10760296251405417","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10760296251405417","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10760296251405417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:05:30Z","timestamp":1777385130000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10760296251405417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":78,"alternative-id":["10.1177\/10760296251405417"],"URL":"https:\/\/doi.org\/10.1177\/10760296251405417","relation":{},"ISSN":["1076-0296","1938-2723"],"issn-type":[{"value":"1076-0296","type":"print"},{"value":"1938-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]},"article-number":"10760296251405417"}}